Are you Dr. Powell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 Fairmount Ave
Suite 415
Pasadena, CA 91105Phone+1 626-449-8440Fax+1 626-449-8999
Summary
- Dr. Mark Powell, MD is a pediatrician in Pasadena, California. He is currently licensed to practice medicine in California. He is affiliated with Huntington Health, Children's Hospital Los Angeles, and Ronald Reagan UCLA Medical Center.
Education & Training
- Cedars-Sinai Medical CenterResidency, Pediatrics, 1989 - 1992
- David Geffen School of Medicine at UCLAClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - 2026
- National Board of Physicians and Surgeons Pediatrics
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Exosome Cargo From Preeclampsia Patients Start of enrollment: 2019 Dec 02
Publications & Presentations
PubMed
- 11 citationsA risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte populationTaekyu Kang, Christina Yau, Christopher K. Wong, John Zachary Sanborn, Yulia Newton
Breast Cancer Research. 2020-07-31 - 148 citationsMultiple Roles for the Receptor Tyrosine Kinase Axl in Tumor FormationSacha Holland, Mark D. Powell, Christian Franci, Emily Chan, Annabelle M. Friera
Cancer Research. 2005-10-15 - 3 citationsCancer and Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy Carrying a Common IGF1R Variant.Mark Powell, Suzanne M. Dufault, Erica P. Gunderson, Christopher C. Benz
Mayo Clinic Proceedings. 2020-11-06
Press Mentions
- Technical Writing for Pharma, Biotech and Medical Devices (Zurich, Switzerland - April 27-28, 2020) - ResearchAndMarkets.comMarch 3rd, 2020
- Technical Writing for Pharma, Biotech and Medical Devices (Singapore - March 30-31, 2020) - ResearchAndMarkets.comMarch 3rd, 2020